Australia's most trusted
source of pharma news
Tuesday, 21 January 2025
Posted 6 June 2024 PM
A partnership involving CSL Seqirus that has saved more than 2,000 lives through access to antivenoms in Papua New Guinea (PNG) over the past six years has been extended out until 2027.
The PNG Snakebite Partnership is an initiative of the company, the Australian government and PNG's National Department of Health to help save the lives of people bitten by venomous snakes or stung marine creatures.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.